Description: Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company's segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe. The Genus ABS segment is engaged in bovine sales business, excluding Asia, and serves dairy and beef customers in North America, Latin America and Europe. The Genus Asia segment is engaged in porcine and bovine business in Asia, and serves porcine, dairy and beef customers in Asian markets. In the porcine market, it sells boars and sows. In the dairy and beef markets, its primary product is bull semen. The Company offers embryos through its subsidiary, In Vitro Brasil S.A. Its porcine business has a network of over 600 breeding herds in approximately 40 countries.
Home Page: www.genusplc.com
GNS Technical Analysis
Matrix House
Basingstoke,
RG21 4DZ
United Kingdom
Phone:
44 1256 347 100
Officers
Name | Title |
---|---|
Mr. Stephen Wilson | CEO & Exec. Director |
Ms. Alison Henriksen | CFO & Exec. Director |
Dr. William Christianson | Chief Operating Officer |
Dr. Elena Rice | Head of R&D and Chief Scientific Officer |
Mr. Dan Hartley | Group Gen. Counsel & Company Sec. |
Ms. Angelle R. Rosata | Group HR Director |
Mr. Jerry Thompson | Chief Operating Officer of Genus ABS Beef |
Dr. Nate Zwald | Chief Operating Officer of Genus ABS Dairy |
Ms. Janet Duane | Group Financial Controller |
Exchange: LSE
Country: UK : United Kingdom
Currency: Pence sterling (p)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Biotechnology |
GIC Sub-Industry: | Biotechnology |
Forward PE: | 32.8947 |
---|---|
Trailing PE: | 48.0923 |
Price-to-Book MRQ: | 3.4219 |
Price-to-Sales TTM: | 3.3386 |
IPO Date: | |
Fiscal Year End: | June |
Full Time Employees: | 3500 |